PMVP logo

PMV Pharmaceuticals (PMVP) Company Overview

Profile

Full Name:

PMV Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

September 25, 2020

Indexes:

Not included

Description:

PMV Pharmaceuticals focuses on developing innovative cancer treatments. The company uses its proprietary technology to discover and create new drugs that target specific cancer cells, aiming to improve patient outcomes and provide effective therapies for various types of cancer.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 28, 2025

Recent annual earnings:

Feb 28, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Aug 20, 24 HC Wainwright & Co.
Buy
May 30, 24 HC Wainwright & Co.
Buy
May 14, 24 HC Wainwright & Co.
Buy
May 13, 24 Craig-Hallum
Buy
Apr 12, 24 Jefferies
Buy
Mar 7, 24 HC Wainwright & Co.
Buy
Dec 27, 23 Ladenburg Thalmann
Buy
Oct 16, 23 HC Wainwright & Co.
Buy
Aug 11, 23 HC Wainwright & Co.
Buy
May 17, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for PMV Pharmaceuticals?
  • Does PMV Pharmaceuticals pay dividends?
  • What sector is PMV Pharmaceuticals in?
  • What industry is PMV Pharmaceuticals in?
  • What country is PMV Pharmaceuticals based in?
  • When did PMV Pharmaceuticals go public?
  • Is PMV Pharmaceuticals in the S&P 500?
  • Is PMV Pharmaceuticals in the NASDAQ 100?
  • Is PMV Pharmaceuticals in the Dow Jones?
  • When was PMV Pharmaceuticals's last earnings report?
  • When does PMV Pharmaceuticals report earnings?
  • Should I buy PMV Pharmaceuticals stock now?

What is the ticker symbol for PMV Pharmaceuticals?

The ticker symbol for PMV Pharmaceuticals is NASDAQ:PMVP

Does PMV Pharmaceuticals pay dividends?

No, PMV Pharmaceuticals does not pay dividends

What sector is PMV Pharmaceuticals in?

PMV Pharmaceuticals is in the Healthcare sector

What industry is PMV Pharmaceuticals in?

PMV Pharmaceuticals is in the Biotechnology industry

What country is PMV Pharmaceuticals based in?

PMV Pharmaceuticals is headquartered in United States

When did PMV Pharmaceuticals go public?

PMV Pharmaceuticals's initial public offering (IPO) was on September 25, 2020

Is PMV Pharmaceuticals in the S&P 500?

No, PMV Pharmaceuticals is not included in the S&P 500 index

Is PMV Pharmaceuticals in the NASDAQ 100?

No, PMV Pharmaceuticals is not included in the NASDAQ 100 index

Is PMV Pharmaceuticals in the Dow Jones?

No, PMV Pharmaceuticals is not included in the Dow Jones index

When was PMV Pharmaceuticals's last earnings report?

PMV Pharmaceuticals's most recent earnings report was on Feb 28, 2025

When does PMV Pharmaceuticals report earnings?

The date for PMV Pharmaceuticals's next earnings report has not been announced yet

Should I buy PMV Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions